Hydrogen: A Rising Star in Gas Medicine as a Mitochondria-Targeting Nutrient via Activating Keap1-Nrf2 Antioxidant System

• Main Authors: Danyu Cheng (Author), Jiangang Long (Author), Lin Zhao (Author), Jiankang Liu (Author)
• Format: Book
• Published: MDPI AG, 2023-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 10.3390/antiox12122062; 2076-3921
• Keywords: hydrogen; gas medicine; antioxidant; mitochondria; Keap1-Nrf2; Nrf2 activator; Therapeutics. Pharmacology; RM1-950
• Source: Antioxidants, Vol 12, Iss 12, p 2062 (2023)

The gas molecules O₂, NO, H₂S, CO, and CH₄, have been increasingly used for medical purposes. Other than these gas molecules, H₂ is the smallest diatomic molecule in nature and has become a rising star in gas medicine in the past few decades. As a non-toxic and easily accessible gas, H₂ has shown preventive and therapeutic effects on various diseases of the respiratory, cardiovascular, central nervous system, and other systems, but the mechanisms are still unclear and even controversial, especially the mechanism of H₂ as a selective radical scavenger. Mitochondria are the main organelles regulating energy metabolism in living organisms as well as the main organelle of reactive oxygen species' generation and targeting. We propose that the protective role of H₂ may be mainly dependent on its unique ability to penetrate every aspect of cells to regulate mitochondrial homeostasis by activating the Keap1-Nrf2 phase II antioxidant system rather than its direct free radical scavenging activity. In this review, we summarize the protective effects and focus on the mechanism of H₂ as a mitochondria-targeting nutrient by activating the Keap1-Nrf2 system in different disease models. In addition, we wish to provide a more rational theoretical support for the medical applications of hydrogen.